Differences in the association between apolipoprotein E genotype and mortality across populations

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 62, Issue 8, 2007, Pages 899-907

  Ewbank, Douglas C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

AGED; ALLELE; ARTICLE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; ETHNIC GROUP; EUROPE; GENOTYPE; HUMAN; JAPANESE; KOREA; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; UNITED STATES; ADULT; CAUSE OF DEATH; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; HEALTH SURVEY; MIDDLE AGED; RISK FACTOR; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; APOLIPOPROTEINS E; CAUSE OF DEATH; EUROPE; GENE FREQUENCY; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; POPULATION SURVEILLANCE; RISK FACTORS; SURVIVAL RATE; UNITED STATES;

EID: 34548711453     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/62.8.899     Document Type: Article

References (74)

1. Farrer LA, Cupples LA, Haines JL, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. JAMA. 1997;278:1349-1356.
2. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155:487-495.
3. Ordovas JM. Cardiovascular disease genetics: a long and winding road. Curr Opin Lipidol. 2003;14:47-54.
4. Song Y, Stampfer MJ, Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med. 2004;141:137-147.
5. Ewbank DC. Mortality differences by APOE genotype estimated from demographic synthesis. Genet Epidemiol. 2002;22:146-155.
6. Ewbank DC. The APOE gene and differences in life expectancy in Europe. J Gerontol Biol Sci Med Sci. 2004;59A:8-12.
7. Lee JH, Tang MX, Schupf N, et al. Mortality and apolipoprotein E in Hispanic, African-American, and Caucasian elders. Am J Med Genet. 2001;103:121-127.
8. Fillenbaum GG, Blazer DG, Burchett BM, Saunders AM, Taylor DH Jr. Apolipoprotein E epsilon4 and risk of mortality in African American and white older community residents. Gerontologist. 2002;42:381-386.
9. Fillenbaum GG, Burchett BM, Lee JH, Blazer DG. Mortality and apolipoprotein E in African-American, and white elders: an attempted replication. Am J Med Genet A. 2003;119:141-146.
10. Lane KA, Gao S, Hui SL, Murrell JR, Hall KS, Hendrie HC. Apolipoprotein E and mortality in African-Americans and Yoruba. J Alzheimer's Dis. 2003;5:383-390.
11. Asada T, Kariya T, Yamagata Z, Kinoshita T, Asaka A. Apolipoprotein E allele in centenarians. Neurology. 1996;46:1484.
12. Asada T, Kariya T, Yamagata Z, Kinoshita T, Asaka A. ApoE epsilon 4 allele and cognitive decline in patients with Alzheimer's disease. Neurology. 1996;47:603.
13. Arai Y, Hirose N, Nakazawa S, et al. Lipoprotein metabolism in Japanese centenarians: effects of apolipoprotein E polymorphism and nutritional status. J Am Geriatr Soc. 2001;49:1434-1441.
14. Desai PP, Hendrie HC, Evans RM, Murrell JR, DeKosky ST, Kamboh MI. Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans. Am J Med Genet B Neuropsychiatr Genet. 2003;116:98-101.
15. Kamboh MI, Evans RW, Aston CE. Genetic effect of apolipoprotein(a) and apolipoprotein E polymorphisms on plasma quantitative risk factors for coronary heart disease in American black women. Atherosclerosis. 1995;117:73-81.
16. Hsu CC, Kao WHL, Coresh J, et al. Apolipoprotein E and progression of chronic kidney disease. JAMA. 2005;293:2892-2899.
17. Goldman N, Glei DA, Chang M-C. The role of clinical risk factors in understanding self-rated health. Ann Epidemiol. 2004;14:49-57.
18. Kardaun JW, White L, Resnick HE, et al. Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in the Honolulu-Asia Aging Study. Clin Chem. 2000;46:1548-1554.
19. Launer LJ, White LR, Petrovitch H, Ross GW, Curb JD. Cholesterol and neuropathologic markers of AD: a population-based autopsy study. Neurology. 2001;57:1447-1452.
20. Jian-Gang Z, Yong-Xing M, Chuan-Fu W, et al. Apolipoprotein E and longevity among Han Chinese population. Mech Ageing Dev. 1998;104:159-167.
21. Thelma BK, Juyal RC, Dodge HH, Pandav R, Chandra V, Ganguli M. APOE polymorphism in a rural older population-based sample in India. Hum Biol. 2001;73:135-144.
22. Xu Y, Berglund L, Ramakrishnan R, et al. A common Hpa I RFLP of apolipoprotein C-I increases gene transcription and exhibits an ethnically distinct pattern of linkage disequilibrium with the alleles of apolipoprotein E. J Lipid Res. 1999;40:50-58.
23. Shi J, Zhang S, Ma C, et al. Association between apolipoprotein CI Hpal polymorphism and sporadic Alzheimer's disease in Chinese. Acta Neurol Scand. 2004;109:140-145.
24. Stengard JH, Clark AG, Weiss KM, et al. Contributions of 18 additional DNA sequence variations in the gene encoding apolipoprotein E to explaining variation in quantitative measures of lipid metabolism. Am J Hum Genet. 2002;71:501-517.
25. Lambert JC, Araria-Goumidi L, Myllykangas L, et al. Contribution of APOE promoter polymorphisms to Alzheimer's disease risk. Neurology. 2002;59:59-66.
26. Heijmans BT, Slagboom PE, Gussekloo J, et al. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age. Am J Med Genet. 2002;107:201-208.
27. Nickerson DA, Taylor SL, Fullerton SM, et al. Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res. 2000;10:1532-1545.
28. Schiele F, De Bacquer D, Vincent-Viry M, et al. Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project. Atherosclerosis. 2000;152:475-488.
29. Haddy N, De Bacquer D, Chemaly MM, et al. The importance of plasma apolipoprotein E concentration in addition to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe. Eur J Hum Genet. 2002;10:841-850.
30. Kim JJ, Verdu P, Pakstis AJ, Speed WC, Kidd JR, Kidd KK. Use of autosomal loci for clustering individuals and populations of East Asian origin. Hum Genet. 2005;117:511-519.
31. Selvin S. Statistical Analysis of Epidemiologic Data. New York: Oxford University Press; 1991.
32. Louhija J, Viitanen M, Agüero-Torres H, Tilvis R. Survival in Finnish centenarians in relation to apolipoprotein E polymorphism. J Am Geriatr Soc. 2001;49:1007-1008.
33. Juva K, Verkkoniemi A, Viramo P, et al. APOE epsilon4 does not predict mortality, cognitive decline, or dementia in the oldest old. Neurology. 2000;54:412-415.
34. Raiha I, Marniemi J, Puukka P, Toikka T, Ehnholm C, Sourander L. Effect of serum lipids, lipoproteins, and apolipoproteins on vascular and nonvascular mortality in the elderly. Arterioscler Thromb Vasc Biol. 1997;17:1224-1232.
35. Stengård JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation. 1995;91:265-269.
36. Slooter AJ, Cruts M, Hofman A, et al. The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study. Neurology. 2004;62:1196-1198.
37. Corder EH, Lannfelt L, Viitanen M, et al. Apolipoprotein E genotype determines survival in the oldest old (85 years or older) who have good cognition. Arch Neurol. 1996;53:418-422.
38. Aevarsson O, Svanborg A, Skoog I. Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. Arch Neurol. 1998;55:1226-1232.
39. Baggio G, Franceshi C, Mari D, Herskind AM, Andersen-Ranberg K, Jeune B. Biology and genetics of human longevity. Australasian J Aging. 1998;17:8-10.
40. Gerdes LU, Jeune B, Ranberg KA, Nybo H, Vaupel JW. Estimation of apolipoprotein E genotype-specific relative mortality risks from the distribution of genotypes in centenarians and middle-aged men: apolipoprotein E gene is a "frailty gene," not a "longevity gene." Genet Epidemiol. 2000;19:202-210.
41. Tan QH, Christiansen L, Christensen K, Kruse TA, Bathum L. Apolipoprotein E genotype frequency patterns in aged Danes as revealed by logistic regression models. Eur J Epidemiol. 2004;19:651-656.
42. Frisoni GB, Louhija J, Geroldi C, Trabucchi M. Longevity and the epsilon2 allele of apolipoprotein E: the Finnish Centenarians Study. J Gerontol Med Sci. 2001;56A:M75-M78.
43. Kervinen K, Savolainen MJ, Salokannel J, et al. Apolipoprotein E and B polymorphisms-longevity factors assessed in nonagenarians. Atherosclerosis. 1994;105:89-95.
44. Lehtimäki T, Moilanen T, Nikkari T, et al. Regional differences in apolipoprotein E polymorphism in Finland. Ann Med. 1991;23:61-66.
45. Louhija J, Miettinen HE, Kontula K, Tikkanen MJ, Miettinen TA, Tilvis RS. Aging and genetic variation of plasma apolipoproteins. Relative loss of the apolipoprotein E4 phenotype in centenarians. Arterioscler Thromb. 1994;14:1084-1089.
46. Tilvis RS, Strandberg TE, Juva K. Apolipoprotein E phenotypes, dementia and mortality in a prospective population sample. J Am Geriatr Soc. 1998;46:712-715.
47. Blanché H, Cabanne L, Sahbatou M, Thomas G. A study of French centenarians: are ACE and APOE associated with longevity? Comptes Rendus De L'Academie Des Sciences-Serie III. 2001;324:129-135.
48. Rea IM, McDowell I, McMaster D, Smye M, Stout R, Evans A. Apolipoprotein E alleles in nonagenarian subjects in the Belfast Elderly Longitudinal Free-living Ageing Study (BELFAST). Mech Ageing Dev. 2001;122:1367-1372.
49. Corbo RM, Scacchi R, Cresta M. Differential reproductive efficiency associated with common apolipoprotein e alleles in postreproductive-aged subjects. Fertil Steril. 2004;81:104-107.
50. Panza F, Solfrizzi V, Torres F, et al. Decreased frequency of apolipoprotein E epsilon4 allele from Northern to Southern Europe in Alzheimer's disease patients and centenarians. Neurosci Lett. 1999;277:53-56.
51. Feskens EJ, Havekes LM, Kalmijn S, de Knijff P, Launer LJ, Kromhout D. Apolipoprotein e4 allele and cognitive decline in elderly men. Br Med J. 1994;309:1202-1206.
52. Klasen EC, Smit M, de Kniff P, Gevers Leuven J, Kempen-Voogd R, Havekes L. Apolipoprotein E phenotype and gene distribution in The Netherlands. Hum Hered. 1987;37:340-344.
53. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem. 1993;39:2125-2129.
54. Galinsky D, Tysoe C, Brayne CE, et al. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity. Atherosclerosis. 1997;129:177-183.
55. Schächter F, Faure-Delanef L, Guenot FG, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet. 1994;6:29-32.
56. Hayden KM, Zandi PP, Lyketsos CG, et al. Apolipoprotein E genotype and mortality: findings from the Cache County Study. J Am Geriatr Soc. 2005;53:935-942.
57. Vogt MT, Cauley JA, Kuller LH. Apolipoprotein e phenotype, arterial disease, and mortality among older women: the Study of Osteoporotic Fractures. Genet Epidemiol. 1997;14:147-156.
58. Breitner JC, Wyse BW, Anthony JC, et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology. 1999;53:321-331.
59. Ferrucci L, Guralnik JM, Pahor M, et al. Apolipoprotein E epsilon 2 allele and risk of stroke in the older population. Stroke. 1997;28:2410-2416.
60. Manton KG, Gu X, Huang H, Kovtun M. Fuzzy set analyses of genetic determinants of health and disability status. Stat Methods Med Res. 2004;13:395-408.
61. Cauley JA, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH. Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women. Genet Epidemiol. 1993;10:27-34.
62. Schneider JA, Bienias JL, Wilson RS, Berry-Kravis E, Evans DA, Bennett DA. The apolipoprotein E epsilon4 allele increases the odds of chronic cerebral infection detected at autopsy in older persons. Stroke. 2005;36:954-959.
63. Wilson RS, Schneider JA, Barnes LL, et al. The apolipoprotein E epsilon4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002;59:1154-1160.
64. Liu HC, Hong CJ, Wang SJ, et al. ApoE genotype in relation to AD and cholesterol: a study of 2,326 Chinese adults. Neurology. 1999;53:962-966.
65. Asada T, Yamagata Z, Kinoshita T, et al. Prevalence of dementia and distribution of ApoE alleles in Japanese centenarians: an almost-complete survey in Yamanashi Prefecture, Japan. J Am Geriatr Soc. 1996;44:151-155.
66. Eto M, Watanabe K, Ishii K. A racial difference in apolipoprotein E allele frequencies between the Japanese and Caucasian populations. Clin Genet. 1986;30:422-427.
67. Tsuda M, Sanada M, Higashi Y, et al. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women. Clin Endocrinol. 2004;61:619-625.
68. Zaman MM, Ikemoto S, Yoshiike N, Date C, Yokoyama T, Tanaka H. Association of apolipoprotein genetic polymorphisms with plasma cholesterol in a Japanese rural population. The Shibata Study. Arterioscler Thromb Vasc Biol. 1997;17:3495-3504.
69. Yamanouchi Y, Arinami T, Tsuchiya S, et al. Apolipoprotein E5 and E7 in apparently healthy Japanese males: frequencies and relation to plasma lipid levels [abstract]. Jpn J Hum Genet. 1994;39:315-324.
70. Choi YH, Kim JH, Kim DK, et al. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. J Gerontol Biol Sci Med Sci. 2003;58A:227-231.
71. Kim J-M, Stewart R, Shin I-S, Yoon J-S. Vascular disease/risk and late-life depression in a Korean community population. Br J Psychiatry. 2004;185:102-107.
72. Kim HS, Kamboh MI. Genetic polymorphisms of apolipoproteins A-IV, E and H in Koreans. Hum Hered. 1998;48:313-317.
73. Hong SH, Kang BY, Oh JH, Kim JQ, Lee CC. Genetic variations of the apo E-CI-CII cluster gene in Koreans. Clin Biochem. 1997;30:215-219.
74. Namkoong Y, Kim YJ, Lee CC. Genetic studies of Korean population: 24. Genetic polymorphisms of apolipoprotein A-IV and apolipoprotein E. Korean J Genet. 1994;16:33-36.